<i>NTRK</i> Fusions in Central Nervous System Tumors: A Rare, but Worthy Target.

Int J Mol Sci · 2020 · PMC7037946 · PMID 31979374

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

extremely significantno p-value reported

Despite the rarity of NTRK fusions, the potential clinical benefit for the small group of patients harboring these alterations appears to be extremely significant, thus fully awareness by physicians caring for brain tumors is now mandatory.

also in 7,787 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.